论文部分内容阅读
目的观察肾上腺素鼓室注射佐治分泌性中耳炎的疗效。方法将130例(216耳)分泌性中耳炎患者随机分为治疗组88例(144耳)和对照组42例(72耳)。治疗组采用地塞米松、α糜蛋白酶、肾上腺素混合液行鼓室内注射;对照组仅采用地塞米松、α糜蛋白酶混合液进行鼓室内注射。治疗1 个月、6 个月后观察疗效。结果治疗1 个月后有效率治疗组为93.06%,对照组为69.44%,均未发现不良反应。两组治疗1 个月、6 个月后总有效率比较,差异有显著性意义(均P<0.01)。结论地塞米松、α糜蛋白酶、肾上腺素三药联合行鼓室注射可提高分泌性中耳炎的治愈率,且安全可靠。
Objective To observe the effect of epinephrine tympanic injection in the treatment of secretory otitis media. Methods 130 cases (216 ears) of secretory otitis media were randomly divided into treatment group (88 cases) (144 ears) and control group (42 cases) (72 ears). The treatment group received intratympanic injection with dexamethasone, α-chymotrypsin and epinephrine, while the control group received intratympanic injection with dexamethasone and α-chymotrypsin. Treatment for 1 month, 6 months after the observation effect. Results After 1 month of treatment, the effective rate was 93.06% in the treatment group and 69.44% in the control group. No adverse reactions were found. The two groups of treatment 1 month, 6 months after the total efficiency, the difference was significant (P <0.01). Conclusions Dexamethasone, α-chymotrypsin and epinephrine combined with tympanic injection can improve the cure rate of secretory otitis media and be safe and reliable.